Hier finden Sie die direkt aus den bewilligten UroAgeCare-Projekten hervorgegangenen Publikationen.  

2022

• Klümper N, Hölzel M, Eckstein M et.al: Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with enfortumab vedotin resistance. Clin Cancer Res. 2022 Dec 19;CCR-22-1764. doi: 10.1158/1078-0432.CCR-22-1764. Online ahead of print.  Weblinks: https://pubmed.ncbi.nlm.nih.gov/36534531/; https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-22-1764/711754/Membranous-NECTIN-4-expression-frequently.

2023